153 related articles for article (PubMed ID: 28859034)
1. Six Weeks Versus 3 Months of Anticoagulant Treatment for Pediatric Central Venous Catheter-related Venous Thromboembolism.
Smith R; Jones S; Newall F
J Pediatr Hematol Oncol; 2017 Oct; 39(7):518-523. PubMed ID: 28859034
[TBL] [Abstract][Full Text] [Related]
2. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
[TBL] [Abstract][Full Text] [Related]
3. Duration of anticoagulant therapy in pediatric venous thromboembolism: Current approaches and updates from randomized controlled trials.
Tarango C; Schulman S; Betensky M; Goldenberg NA
Expert Rev Hematol; 2018 Jan; 11(1):37-44. PubMed ID: 29183221
[TBL] [Abstract][Full Text] [Related]
4. Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.
Goldenberg NA; Kittelson JM; Abshire TC; Bonaca M; Casella JF; Dale RA; Halperin JL; Hamblin F; Kessler CM; Manco-Johnson MJ; Sidonio RF; Spyropoulos AC; Steg PG; Turpie AGG; Schulman S;
JAMA; 2022 Jan; 327(2):129-137. PubMed ID: 35015038
[TBL] [Abstract][Full Text] [Related]
5. Current approaches in the treatment of catheter-related deep venous thrombosis in children.
Jaffray J; Goldenberg N
Expert Rev Hematol; 2020 Jun; 13(6):607-617. PubMed ID: 32290724
[TBL] [Abstract][Full Text] [Related]
6. Catheter-Related Venous Thrombosis in Hospitalized Pediatric Patients with Inflammatory Bowel Disease: Incidence, Characteristics, and Role of Anticoagulant Thromboprophylaxis with Enoxaparin.
Diamond CE; Hennessey C; Meldau J; Guelcher CJ; Guerrera MF; Conklin LS; Sharma KV; Diab YA
J Pediatr; 2018 Jul; 198():53-59. PubMed ID: 29628414
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of malignancy-associated venous thromboembolism among patients treated with rivaroxaban compared to enoxaparin.
Nicklaus MD; Ludwig SL; Kettle JK
J Oncol Pharm Pract; 2018 Apr; 24(3):185-189. PubMed ID: 29284351
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
9. Central Venous Catheter-associated Venous Thromboembolism in Children With Hematologic Malignancy.
Onyeama SN; Hanson SJ; Dasgupta M; Baker K; Simpson PM; Punzalan RC
J Pediatr Hematol Oncol; 2018 Nov; 40(8):e519-e524. PubMed ID: 29863581
[TBL] [Abstract][Full Text] [Related]
10. The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients.
Gonda DD; Fridley J; Ryan SL; Briceño V; Lam SK; Luerssen TG; Jea A
J Neurosurg Pediatr; 2015 Sep; 16(3):329-34. PubMed ID: 26067336
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Symptomatic and Asymptomatic Thrombosis in Pediatric Oncology Patients With Tunneled Central Venous Catheters.
Schoot RA; van de Wetering MD; Stijnen T; Tissing WJ; Michiels E; Abbink FC; Raphael MF; Heij HA; Zwaan M; Lieverst JA; Caron HN; van Ommen H;
Pediatr Blood Cancer; 2016 Aug; 63(8):1438-44. PubMed ID: 27128820
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism in pediatric trauma patients: Ten-year experience and long-term follow-up in a tertiary care center.
Leeper CM; Vissa M; Cooper JD; Malec LM; Gaines BA
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28067012
[TBL] [Abstract][Full Text] [Related]
13. Heparin versus enoxaparin for prevention of venous thromboembolism after trauma: A randomized noninferiority trial.
Olson EJ; Bandle J; Calvo RY; Shackford SR; Dunne CE; Van Gent JM; Zander AL; Sikand H; Bongiovanni MS; Sise MJ; Sise CB
J Trauma Acute Care Surg; 2015 Dec; 79(6):961-8; discussion 968-9. PubMed ID: 26317819
[TBL] [Abstract][Full Text] [Related]
14. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
15. Identification of a "VTE-rich" population in pediatrics - Critically ill children with central venous catheters.
Tran M; Shein SL; Ji X; Ahuja SP
Thromb Res; 2018 Jan; 161():73-77. PubMed ID: 29207322
[TBL] [Abstract][Full Text] [Related]
16. Comparing Length of Stay Between Patients Taking Rivaroxaban and Conventional Anticoagulants for Treatment of Venous Thromboembolism.
Desai A; Desai A; Calixte R; Aparnath M; Hindenburg A; Salzman S; Mathew JP
Lung; 2016 Aug; 194(4):605-11. PubMed ID: 27192990
[TBL] [Abstract][Full Text] [Related]
17. Venous Thromboembolism in Children: Is It Preventable?
Biss TT
Semin Thromb Hemost; 2016 Sep; 42(6):603-11. PubMed ID: 27272961
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic complications in children from short-term percutaneous central venous catheters: what can we do?
Latham GJ; Thompson DR
Paediatr Anaesth; 2014 Sep; 24(9):902-11. PubMed ID: 24814351
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulant therapy management of venous thromboembolism recurrence occurring during anticoagulant therapy: a descriptive study.
Lai N; Jones AE; Johnson SA; Witt DM
J Thromb Thrombolysis; 2021 Aug; 52(2):414-418. PubMed ID: 33486650
[TBL] [Abstract][Full Text] [Related]
20. The impact of quality and duration of enoxaparin therapy on recurrent venous thrombosis in children.
Estepp JH; Smeltzer M; Reiss UM
Pediatr Blood Cancer; 2012 Jul; 59(1):105-9. PubMed ID: 22106013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
